TNGX logo

Tango Therapeutics, Inc. (TNGX) Free Cash Flow

Annual FCF:

-$132.25M-$12.75M(-10.67%)
December 31, 2024

Summary

  • As of today, TNGX annual free cash flow is -$132.25 million, with the most recent change of -$12.75 million (-10.67%) on December 31, 2024.
  • During the last 3 years, TNGX annual free cash flow has fallen by -$70.89 million (-115.53%).
  • TNGX annual free cash flow is now -291.76% below its all-time high of $68.97 million, reached on December 31, 2020.

Performance

TNGX Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTNGXcash flow metrics

Quarterly FCF:

-$31.10M+$6.04M(+16.26%)
September 30, 2025

Summary

  • As of today, TNGX quarterly free cash flow is -$31.10 million, with the most recent change of +$6.04 million (+16.26%) on September 30, 2025.
  • Over the past year, TNGX quarterly free cash flow has increased by +$2.40 million (+7.17%).
  • TNGX quarterly free cash flow is now -135.55% below its all-time high of $87.49 million, reached on September 30, 2020.

Performance

TNGX Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTNGXcash flow metrics

TTM FCF:

-$146.76M+$2.40M(+1.61%)
September 30, 2025

Summary

  • As of today, TNGX TTM free cash flow is -$146.76 million, with the most recent change of +$2.40 million (+1.61%) on September 30, 2025.
  • Over the past year, TNGX TTM free cash flow has dropped by -$23.59 million (-19.15%).
  • TNGX TTM free cash flow is now -267.76% below its all-time high of $87.49 million, reached on September 30, 2020.

Performance

TNGX TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTNGXcash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

TNGX Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-10.7%+7.2%-19.1%
3Y3 Years-115.5%-35.9%-39.7%
5Y5 Years-291.8%-135.6%-267.8%

TNGX Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-115.5%at low-35.9%+25.5%-39.7%+1.6%
5Y5-Year-291.8%at low-135.6%+25.5%-267.8%+1.6%
All-TimeAll-Time-291.8%at low-135.6%+25.5%-267.8%+1.6%

TNGX Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2025
-
-$31.10M(+16.3%)
-$146.76M(+1.6%)
Jun 2025
-
-$37.14M(+11.0%)
-$149.17M(-9.7%)
Mar 2025
-
-$41.75M(-13.5%)
-$135.95M(-2.8%)
Dec 2024
-$132.25M(-10.7%)
-$36.77M(-9.7%)
-$132.25M(-7.4%)
Sep 2024
-
-$33.51M(-40.0%)
-$123.18M(-1.9%)
Jun 2024
-
-$23.93M(+37.1%)
-$120.82M(+1.0%)
Mar 2024
-
-$38.05M(-37.4%)
-$122.03M(-2.1%)
Dec 2023
-$119.51M
-$27.69M(+11.1%)
-$119.51M(+1.3%)
Sep 2023
-
-$31.15M(-23.9%)
-$121.12M(-7.3%)
Jun 2023
-
-$25.14M(+29.2%)
-$112.86M(+6.8%)
DateAnnualQuarterlyTTM
Mar 2023
-
-$35.53M(-21.2%)
-$121.07M(-3.7%)
Dec 2022
-$116.77M(-90.3%)
-$29.31M(-28.0%)
-$116.77M(-11.1%)
Sep 2022
-
-$22.89M(+31.4%)
-$105.06M(-0.6%)
Jun 2022
-
-$33.35M(-6.8%)
-$104.44M(-32.5%)
Mar 2022
-
-$31.23M(-77.4%)
-$78.81M(-28.4%)
Dec 2021
-$61.36M(-189.0%)
-$17.60M(+21.0%)
-$61.36M(+1.5%)
Sep 2021
-
-$22.27M(-188.4%)
-$62.28M(-231.2%)
Jun 2021
-
-$7.72M(+44.0%)
$47.47M(-14.0%)
Mar 2021
-
-$13.78M(+25.6%)
$55.19M(-20.0%)
Dec 2020
$68.97M
-$18.52M(-121.2%)
$68.97M(-21.2%)
Sep 2020
-
$87.49M
$87.49M

FAQ

  • What is Tango Therapeutics, Inc. annual free cash flow?
  • What is the all-time high annual free cash flow for Tango Therapeutics, Inc.?
  • What is Tango Therapeutics, Inc. annual free cash flow year-on-year change?
  • What is Tango Therapeutics, Inc. quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for Tango Therapeutics, Inc.?
  • What is Tango Therapeutics, Inc. quarterly free cash flow year-on-year change?
  • What is Tango Therapeutics, Inc. TTM free cash flow?
  • What is the all-time high TTM free cash flow for Tango Therapeutics, Inc.?
  • What is Tango Therapeutics, Inc. TTM free cash flow year-on-year change?

What is Tango Therapeutics, Inc. annual free cash flow?

The current annual free cash flow of TNGX is -$132.25M

What is the all-time high annual free cash flow for Tango Therapeutics, Inc.?

Tango Therapeutics, Inc. all-time high annual free cash flow is $68.97M

What is Tango Therapeutics, Inc. annual free cash flow year-on-year change?

Over the past year, TNGX annual free cash flow has changed by -$12.75M (-10.67%)

What is Tango Therapeutics, Inc. quarterly free cash flow?

The current quarterly free cash flow of TNGX is -$31.10M

What is the all-time high quarterly free cash flow for Tango Therapeutics, Inc.?

Tango Therapeutics, Inc. all-time high quarterly free cash flow is $87.49M

What is Tango Therapeutics, Inc. quarterly free cash flow year-on-year change?

Over the past year, TNGX quarterly free cash flow has changed by +$2.40M (+7.17%)

What is Tango Therapeutics, Inc. TTM free cash flow?

The current TTM free cash flow of TNGX is -$146.76M

What is the all-time high TTM free cash flow for Tango Therapeutics, Inc.?

Tango Therapeutics, Inc. all-time high TTM free cash flow is $87.49M

What is Tango Therapeutics, Inc. TTM free cash flow year-on-year change?

Over the past year, TNGX TTM free cash flow has changed by -$23.59M (-19.15%)
On this page